Dendritic cells can effectively be pulsed by HBVsvp and induce specific immune reactions in mice

Vaccine

Volumn 29, Issue 2, 2010, Pages 200-206

  Farag, Mohamed M S ^a,b   Hoyler, Birgit ^a   Encke, Jens ^a,c   Stremmel, Wolfgang ^a   Weigand, Kilian ^b  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b Assiut Branch   (Egypt)

^c JOHANNA ETIENNE KRANKENHAUS   (Germany)

Author keywords

Cell based therapy; Chronic viral hepatitis; Hepatitis B virus; Immunology; T cells

Indexed keywords

CD86 ANTIGEN; CHEMOKINE RECEPTOR CCR7; DENDRITIC CELL VACCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; ENZYME LINKED IMMUNOSPOT ASSAY; EX VIVO STUDY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HEPATITIS B; HEPATITIS B VIRUS; IMMUNE RESPONSE; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEROCONVERSION; VACCINATION;

ANIMALS; ANTIGENS, CD86; CELL LINE; CELL PROLIFERATION; DENDRITIC CELLS; FLOW CYTOMETRY; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HEPATOCYTES; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RECEPTORS, CCR7; T-LYMPHOCYTES; VIRION;

EID: 78649692835     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.10.056     Document Type: Article

References (46)

1. Bertoletti A., Gehring A.J. The immune response during hepatitis B virus infection. J Gen Virol 2006, 87:1439-1449.
2. Rehermann B., Fowler P., Sidney J., Person J., Redeker A., Brown M., et al. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J Exp Med 1995, 181:1047-1058.
3. Ganem D., Prince A.M. Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med 2004, 350:1118-1129.
4. Maini M.K., Boni C., Ogg G.S., King A.S., Reignat S., Lee C.K., et al. Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection. Gastroenterology 1999, 117:1386-1396.
5. Webster G.J., Reignat S., Maini M.K., Whalley S.A., Ogg G.S., King A., et al. Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms. Hepatology 2000, 32:1117-1124.
6. Lok A.S., McMahon B.J. Chronic hepatitis B. Hepatology 2001, 34:1225-1241.
7. Guidotti L.G., Rochford R., Chung J., Shapiro M., Purcell R., Chisari F.V. Viral clearance without destruction of infected cells during acute HBV infection. Science 1999, 284:825-829.
8. Thimme R., Wieland S., Steiger C., Ghrayeb J., Reimann K.A., Purcell R.H., et al. CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J Virol 2003, 77:68-76.
9. Menne S., Roneker C.A., Roggendorf M., Gerin J.L., Cote P.J., Tennant B.C. Deficiencies in the acute-phase cell-mediated immune response to viral antigens are associated with development of chronic woodchuck hepatitis virus infection following neonatal inoculation. J Virol 2002, 76:1769-1780.
10. Marinos G., Torre F., Chokshi S., Hussain M., Clarke B.E., Rowlands D.J., et al. Induction of T-helper cell response to hepatitis B core antigen in chronic hepatitis B: a major factor in activation of the host immune response to the hepatitis B virus. Hepatology 1995, 22:1040-1049.
11. Maini M.K., Boni C., Lee C.K., Larrubia J.R., Reignat S., Ogg G.S., et al. The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med 2000, 191:1269-1280.
12. Nakamura I., Nupp J.T., Cowlen M., Hall W.C., Tennant B.C., Casey J.L., et al. Pathogenesis of experimental neonatal woodchuck hepatitis virus infection: chronicity as an outcome of infection is associated with a diminished acute hepatitis that is temporally deficient for the expression of interferon gamma and tumor necrosis factor-alpha messenger RNAs. Hepatology 2001, 33:439-447.
13. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
14. Moretta A. Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat Rev Immunol 2002, 2:957-964.
15. Lanzavecchia A., Sallusto F. Regulation of T cell immunity by dendritic cells. Cell 2001, 106:263-266.
16. Op den Brouw M.L., Binda R.S., van Roosmalen M.H., Protzer U., Janssen H.L., van der Molen R.G., et al. Hepatitis B virus surface antigen impairs myeloid dendritic cell function: a possible immune escape mechanism of hepatitis B virus. Immunology 2009, 126:280-289.
17. Lanzavecchia A., Sallusto F. Antigen decoding by T lymphocytes: from synapses to fate determination. Nat Immunol 2001, 2:487-492.
18. Steinman R.M., Hawiger D., Nussenzweig M.C. Tolerogenic dendritic cells. Annu Rev Immunol 2003, 21:685-711.
19. Beckebaum S., Cicinnati V.R., Dworacki G., Muller-Berghaus J., Stolz D., Harnaha J., et al. Reduction in the circulating pDC1/pDC2 ratio and impaired function of ex vivo-generated DC1 in chronic hepatitis B infection. Clin Immunol 2002, 104:138-150.
20. Beckebaum S., Cicinnati V.R., Zhang X., Ferencik S., Frilling A., Grosse-Wilde H., et al. Hepatitis B virus-induced defect of monocyte-derived dendritic cells leads to impaired T helper type 1 response in vitro: mechanisms for viral immune escape. Immunology 2003, 109:487-495.
21. van der Molen R.G., Sprengers D., Binda R.S., de Jong E.C., Niesters H.G., Kusters J.G., et al. Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B. Hepatology 2004, 40:738-746.
22. Duan X.Z., Zhuang H., Wang M., Li H.W., Liu J.C., Wang F.S. Decreased numbers and impaired function of circulating dendritic cell subsets in patients with chronic hepatitis B infection (R2). J Gastroenterol Hepatol 2005, 20:234-242.
23. Shi M., Fu J., Shi F., Zhang B., Tang Z., Zhang Z., et al. Viral suppression correlates with dendritic cell restoration in chronic hepatitis B patients with autologous cytokine-induced killer cell transfusion. Liver Int 2009, 29:466-474.
24. Boonstra A., Woltman A.M., Janssen H.L. Immunology of hepatitis B and hepatitis C virus infections. Best Pract Res Clin Gastroenterol 2008, 22:1049-1061.
25. Akbar S.M., Horiike N., Onji M. Immune therapy including dendritic cell based therapy in chronic hepatitis B virus infection. World J Gastroenterol 2006, 12:2876-2883.
26. Cohen S., Haimovich J., Hollander N. Dendritic cell-based therapeutic vaccination against myeloma: vaccine formulation determines efficacy against light chain myeloma. J Immunol 2009, 182:1667-1673.
27. Ma X.J., Tian D.Y., Xu D., Yang D.F., Zhu H.F., Liang Z.H., et al. Uric acid enhances T cell immune responses to hepatitis B surface antigen-pulsed-dendritic cells in mice. World J Gastroenterol 2007, 13:1060-1066.
28. Qiu S.J., Lu L., Qiao C., Wang L., Wang Z., Xiao X., et al. Induction of tumor immunity and cytotoxic t lymphocyte responses using dendritic cells transduced by adenoviral vectors encoding HBsAg: comparison to protein immunization. J Cancer Res Clin Oncol 2005, 131:429-438.
29. Sells M.A., Chen M.L., Acs G. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci USA 1987, 84:1005-1009.
30. Inaba K., Inaba M., Romani N., Aya H., Deguchi M., Ikehara S., et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 1992, 176:1693-1702.
31. Zanoni I., Ostuni R., Capuano G., Collini M., Caccia M., Ronchi A.E., et al. CD14 regulates the dendritic cell life cycle after LPS exposure through NFAT activation. Nature 2009.
32. Lyons A.B. Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. J Immunol Methods 2000, 243:147-154.
33. Schirmbeck R., Reimann J. Modulation of gene-gun-mediated Th2 immunity to hepatitis B surface antigen by bacterial CpG motifs or IL-12. Intervirology 2001, 44:115-123.
34. Feili-Hariri M., Dong X., Alber S.M., Watkins S.C., Salter R.D., Morel P.A. Immunotherapy of NOD mice with bone marrow-derived dendritic cells. Diabetes 1999, 48:2300-2308.
35. Xie Q., Shen H.C., Jia N.N., Wang H., Lin L.Y., An B.Y., et al. Patients with chronic hepatitis B infection display deficiency of plasmacytoid dendritic cells with reduced expression of TLR9. Microbes Infect 2009, 11:515-523.
36. Garcia F., Lejeune M., Climent N., Gil C., Alcami J., Morente V., et al. Therapeutic immunization with dendritic cells loaded with heat-inactivated autologous HIV-1 in patients with chronic HIV-1 infection. J Infect Dis 2005, 191:1680-1685.
37. Connolly N.C., Whiteside T.L., Wilson C., Kondragunta V., Rinaldo C.R., Riddler S.A. Therapeutic immunization with human immunodeficiency virus type 1 (HIV-1) peptide-loaded dendritic cells is safe and induces immunogenicity in HIV-1-infected individuals. Clin Vaccine Immunol 2008, 15:284-292.
38. Zheng B.J., Zhou J., Qu D., Siu K.L., Lam T.W., Lo H.Y., et al. Selective functional deficit in dendritic cell-T cell interaction is a crucial mechanism in chronic hepatitis B virus infection. J Viral Hepat 2004, 11:217-224.
39. Andrew K.A., Simkins H.M., Witzel S., Perret R., Hudson J., Hermans I.F., et al. Dendritic cells treated with lipopolysaccharide up-regulate serine protease inhibitor 6 and remain sensitive to killing by cytotoxic T lymphocytes in vivo. J Immunol 2008, 181:8356-8362.
40. Paul W.E., Zhu J. How are T(H)2-type immune responses initiated and amplified?. Nat Rev Immunol 2010, 10:225-235.
41. Phillipps K.S., Wykes M.N., Liu X.Q., Brown M., Blanchfield J., Toth I. A novel synthetic adjuvant enhances dendritic cell function. Immunology 2009, 128:e582-588.
42. Gamvrellis A., Leong D., Hanley J.C., Xiang S.D., Mottram P., Plebanski M. Vaccines that facilitate antigen entry into dendritic cells. Immunol Cell Biol 2004, 82:506-516.
43. Huang Y., Chen Z., Jia H., Wu W., Zhong S., Zhou C. Induction of Tc1 response and enhanced cytotoxic T lymphocyte activity in mice by dendritic cells transduced with adenovirus expressing HBsAg. Clin Immunol 2006, 119:280-290.
44. Li A., Li Z., Ma S., Su Q., Zhang S., Sun X., et al. Dysfunction of splenic macrophages in cirrhotic patients with hypersplenism and HBV infection. Am J Med Sci 2008, 336:32-38.
45. Guidotti L.G., Matzke B., Schaller H., Chisari F.V. High-level hepatitis B virus replication in transgenic mice. J Virol 1995, 69:6158-6169.
46. Chisari F.V., Pinkert C.A., Milich D.R., Filippi P., McLachlan A., Palmiter R.D., et al. A transgenic mouse model of the chronic hepatitis B surface antigen carrier state. Science 1985, 230:1157-1160.